Information Provided By:
Fly News Breaks for January 13, 2016
CME, JNS
Jan 13, 2016 | 07:02 EDT
JPMorgan analyst Kenneth Worthington downgraded Janus Capital (JNS) to Neutral saying weak market fundamentals will likely hit the company harder than peers given its concentrated exposure to equities. He has a $15 price target for the shares. Worthington coupled the downgrade with an upgrade of CME Group (CME) to Overweight.
News For JNS;CME From the Last 2 Days
There are no results for your query JNS;CME